|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2004-9-14
|
|
pubmed:abstractText |
Autoimmune hepatitis (AIH) is an immune mediated chronic liver disease with a prevalence of 17 cases/100,000. Resistance to the standard treatment of AIH (prednisone and azathioprine) occurs in 15% to 20%. There is currently no standard treatment of patients with steroid refractory AIH.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0192-0790
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
38
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
805-9
|
|
pubmed:meshHeading |
pubmed-meshheading:15365410-Adult,
pubmed-meshheading:15365410-Aged,
pubmed-meshheading:15365410-Aged, 80 and over,
pubmed-meshheading:15365410-Azathioprine,
pubmed-meshheading:15365410-Biopsy,
pubmed-meshheading:15365410-Female,
pubmed-meshheading:15365410-Fibrosis,
pubmed-meshheading:15365410-Follow-Up Studies,
pubmed-meshheading:15365410-Hepatitis, Autoimmune,
pubmed-meshheading:15365410-Humans,
pubmed-meshheading:15365410-Immunosuppressive Agents,
pubmed-meshheading:15365410-Liver,
pubmed-meshheading:15365410-Male,
pubmed-meshheading:15365410-Middle Aged,
pubmed-meshheading:15365410-Prednisone,
pubmed-meshheading:15365410-Steroids,
pubmed-meshheading:15365410-Tacrolimus,
pubmed-meshheading:15365410-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis.
|
|
pubmed:affiliation |
Division of Hepatology and Gastroenterology Mayo Clinic, Jacksonville, Florida 32216, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
